Heyser C J, Hampson R E, Deadwyler S A
Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
J Pharmacol Exp Ther. 1993 Jan;264(1):294-307.
The effects of delta-9-tetrahydrocannabinol (delta-9-THC) were studied during performance of a delayed match to sample (DMTS) task in rats. Correlated hippocampal cellular activity was also assessed in terms of the effects of cannabinoids on well characterized task specific changes in firing rate which occurred during various phases of a DMTS trial. Results show a surprising correlation between the delay and dose (0.75-2.0 mg/kg)-dependent behavioral deficit produced by delta-9-THC in this task and similar effects produced by damage to the hippocampus and related structures. However, unlike the effects of hippocampal lesions or neurotoxic damage, the effects of delta-9-THC were completely reversible within 24 hr of injection. Neither control injection of the vehicle nor equivalent concentrations of the nonpsychoactive cannabinoid, cannabidiol, produced alterations in DMTS performance levels. Simultaneous recordings from identified hippocampal complex spike cells at the highest dose of drug indicated that the DMTS deficit was associated with a specific decrease in hippocampal cell discharge during the Sample (but not the Match) phase of the task. In nine identified neurons (including four observed during both control and drug conditions) recorded from six different animals in which the effects of delta-9-THC were manifested, no indication of Sample phase firing was observed. Although there were slight but significant reductions in Match and Reinforcement phase related firing during THC sessions, highly significant increases in firing in these phases were still present, indicating that elimination of Sample phase firing did not reflect a nonspecific effect of delta-9-THC on hippocampal cell activity. These findings strongly suggest that performance of the DMTS task was selectively impaired by the lack of Sample phase discharge of hippocampal neurons during the DMTS trial, and that this effect could serve as the basis for the well characterized short-term memory and other cognitive deficits reported in humans after smoking marijuana.
在大鼠进行延迟匹配样本(DMTS)任务期间,研究了δ-9-四氢大麻酚(δ-9-THC)的作用。还根据大麻素对DMTS试验不同阶段发生的、特征明确的任务特异性放电率变化的影响,评估了相关的海马细胞活动。结果显示,在该任务中,δ-9-THC产生的延迟和剂量(0.75 - 2.0毫克/千克)依赖性行为缺陷与海马体及相关结构损伤产生的类似效应之间存在惊人的相关性。然而,与海马体损伤或神经毒性损伤的效应不同,δ-9-THC的效应在注射后24小时内完全可逆。注射溶剂的对照注射以及非精神活性大麻素大麻二酚的等效浓度均未引起DMTS性能水平的改变。在最高药物剂量下对已识别的海马复合棘状细胞进行同步记录表明,DMTS缺陷与任务样本(而非匹配)阶段海马细胞放电的特异性减少有关。在六只不同动物中记录的九个已识别神经元(包括在对照和药物条件下均观察到的四个)中,δ-9-THC的效应得以体现,未观察到样本阶段放电的迹象。尽管在THC给药期间,匹配和强化阶段相关放电略有但显著减少,但这些阶段的放电仍有高度显著的增加,这表明样本阶段放电的消除并非反映δ-9-THC对海马细胞活动的非特异性影响。这些发现强烈表明,DMTS任务的表现因DMTS试验期间海马神经元样本阶段放电的缺乏而受到选择性损害,并且这种效应可能是人类吸食大麻后所报告的特征明确的短期记忆和其他认知缺陷的基础。